Applied Molecular Therapies Pty Ltd is a joint venture between Cyclotek Pty Ltd and Australian Nuclear Science and Technology Organisation (ANSTO). The company has been established to develop, manufacture and supply TGA/cGMP compliant range of radiopharmaceutical theranostics, initially focussed on the use of the radionuclide 177Lu(n.c.a). As a Contract Development and Manufacturing Organisation (CDMO) for theranostic radiopharmaceuticals in Australia, the company’s aim is to ensure that patients, their families and clinicians can be assured that these therapeutic goods will meet all the safety and quality standards expected of a medicine and the manufacturing process is fully compliant with Australia’s regulatory frameworks for clinical trials, Special Access Scheme and ongoing supply of approved therapeutic goods.
Company Details
- Founded
- -
- Address
- Melbourne, Victoria, Au
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Melbourne, Victoria
Applied Molecular Therapies Questions
Applied Molecular Therapies's website is https://appliedmoleculartherapies.com.au
Applied Molecular Therapies's LinkedIn profile is https://au.linkedin.com/company/applied-molecular-therapies
Applied Molecular Therapies's industry is
Pharmaceutical Manufacturing
Applied Molecular Therapies's top competitors are
Rqs Alexander Ruffani,
Full-Life Technologies,
Omicron Biochemicals, Inc.,
Cyclotek Pty Ltd,
Nucleus Radiopharma,
Nanomab,
Actinium Pharmaceuticals, Inc.,
Apitope,
Canadian Medical Isotope Ecosystem,
Theragnostics.
Applied Molecular Therapies's categories are Pharmaceutical Manufacturing
Applied Molecular Therapies's founding year is 2021
